ZipLine Medical, Inc. was selected as a winner of the Red Herring Top 100 North America award, which recognizes the continent’s most exciting and innovative private technology companies.
Winners were chosen from thousands of entrants in a gamut of verticals, from financial technology to marketing, and medical devices to Internet of things. Companies were judged by industry experts, insiders and journalists on a wide variety of criteria, including financial performance, innovation, business strategy, and market penetration. Red Herring’s editors have been evaluating the world’s startups and tech companies for over two decades and their insights enable them to select firms that will continue on a trajectory to success. Brands such as Alibaba, Google, Kakao, Skype, Spotify, Twitter and YouTube have all been singled out as Red Herring winners in the past.
The Zip® Surgical Skin Closure and PreLoc Wound Closure devices have seen significant adoption in key surgical procedures such as total joint replacement and limb salvage. In addition to the economic benefits these devices provide to the hospital and clinic, the high degree of patient satisfaction they engender has created word of mouth that often drives a patient’s friends and family to request ZipLine devices for their next surgery.
“Adoption of the Zip device in our procedures represents the cutting edge of surgery. Orthopedic patients are becoming more and more educated on the products and techniques that offer the best surgical outcomes, and come to the table expecting these from their surgeon,” said Robert C. Marchand MD, orthopedic surgeon and robotic joint replacement expert in Wakefield, Rhode Island. “The Zip enables us to provide patients with a more comfortable recovery and better cosmetic outcome while reducing surgical procedure time and patient complications that add costs to the healthcare system.
MVM Closes Oversubscribed Fund at $500 Million Hard Cap
November 14, 2022
BOSTON & LONDON — MVM Partners is pleased to announce the closing of its sixth healthcare fund, MVM VI, with […]
MVM Invests in Ossio
October 18, 2022
Proceeds will be used to strengthen awareness for the patient benefits of bio-integrative OSSIOfiber® implants and accelerate new product platforms into the major […]
MVM invests in Neurolens
September 12, 2022
Neurolens, a company commercializing innovative solutions to optimize vision, today announced completion of a $67 million financing. The financing was led by […]
MDxHealth acquires Oncotype DX GPS test
August 2, 2022
MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company”), a commercial-stage precision diagnostics company, today announced it has entered into an […]
Nalu announces new CEO
July 14, 2022
Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced today […]
MVM invests in Nalu Medical
February 17, 2022
CARLSBAD, Calif. (PRWEB) February 17, 2022 Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for […]
Clarivate acquires Patient Connect
December 22, 2021
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that […]
MVM invests in Vero Biotech
December 15, 2021
VERO Biotech Inc., a fast-growing commercial business dedicated to improving the lives of patients through innovative technologies, today announced the […]
MVM invests In Optinose
November 18, 2021
MVM invested $20 million in Optinose. Optinose markets XHANCE, an innovative drug delivery system that delivers steroids high and deep […]